Overall, these behavioral findings provide important insights into the mechanisms underlying the cognitive-enhancing effects of Apelin-13 and underscore the therapeutic potential of targeting the Nrf2-HO1 pathway for the treatment of Alzheimer’s disease. The gene discussed is HMOX1; the disease is early-onset autosomal dominant Alzheimer disease.